Expressing support for the designation of July 15, 2026, as "Glioblastoma Awareness Day".

This resolution expresses strong support for designating July 15, 2026, as "Glioblastoma Awareness Day" to raise public understanding of this devastating disease. Glioblastoma is the most common and aggressive malignant brain tumor, with a very low 5-year survival rate and significant challenges in treatment and early detection. The resolution highlights the urgent need for increased awareness regarding the unmet medical needs of patients and the opportunities for research advancements. It honors individuals living with or lost to glioblastoma and recognizes the critical role of patients and caregivers in furthering research. Furthermore, the resolution supports efforts to develop more effective treatments that can improve the long-term prognosis and quality of life for patients. It emphasizes the importance of molecular biomarker testing for diagnosis and urges a collaborative approach to brain tumor research among governmental, private, and nonprofit organizations. Finally, the resolution encourages continued investments in glioblastoma research and treatments, specifically mentioning initiatives like the Glioblastoma Therapeutics Network , to accelerate progress toward cures and enhanced patient care.